Fundraising Fox

Vigeo Therapeutics

Boston, US · Founded 2011 · Delaware corporation

Biotech

Founders & leadership

PB
Peter B FinnExecutive

Board

JD
Jason DingesBoard director
SO
Stephanie O'BrienBoard director

Reported raises · per SEC filings

Form D private placements

$17.6M disclosed across 3 rounds · 2015–2021

▶$7.5MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jing WatnickExecutive Officer, Director
  • Peter B. FinnExecutive Officer
  • Stephanie O'BrienDirector
  • Westerly Nolin, Ph.D.Director
  • James E. MahoneyDirector
Offering amount
$17.5M
Amount sold
$7.5M
Minimum investment
$7.5M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$7.6MraisedMar 2021 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James E. MahoneyDirector
  • Stephanie O'BrienDirector
  • Peter B. FinnExecutive Officer
  • Jing WatnickExecutive Officer, Director
  • Westerly Nolin, Ph.D.Director
Offering amount
$7.6M
Amount sold
$7.6M
Minimum investment
$7.6M
First sale
Mar 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.5MraisedJun 2015 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jason DingesDirector
  • Peter B FinnExecutive Officer, Director
  • Stephanie O'BrienDirector
Offering amount
$10M
Amount sold
$2.5M
Minimum investment
$2.5M
Proceeds to insiders
$1.9M
First sale
Jun 2015
Incorporated
Corporation, Delaware, 2011
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Vigeo Therapeutics raised?
Vigeo Therapeutics has disclosed $17.6M raised across 3 rounds.
Where is Vigeo Therapeutics headquartered?
Vigeo Therapeutics is headquartered in Boston, US.